Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05847062
Other study ID # 22/016-EC_X
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 8, 2022
Est. completion date December 31, 2025

Study information

Verified date May 2023
Source Hospital San Carlos, Madrid
Contact Yaiza Lopiz Morales, professor
Phone +34 609564029
Email yaizalopiz@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To determine the functional outcomes, complications and muscle performance by isokinetic study of two reverse arthroplasty systems (one with medialized center of rotation and the other with lateralized center of rotation) in the treatment of rotator cuff arthropathies or irreparable cuff tears.


Description:

This is an experimental, prospective, unblinded, randomized, comparative clinical trial between patients with two types of prosthetic implants (inverted arthroplasty with medialized center of rotation vs inverted arthroplasty with lateralized center of rotation). Those male or female patients who meet the inclusion criteria will be selected to form part of one of the two randomly distributed study groups. Sample size Based on studies with similar characteristics but where lateralization is not performed with the implant but with a bone graft would require a sample size of 34 patients (17 in each group) assuming 20% losses with a Type I error of 0. 05 and a statistical power of 80% to show a difference of 10 points on the Constant scale (the minimal clinically important difference on the Constant scale for reverse arthroplasty is described as 8 points in previous comparative studies so we consider the detection of a difference of 10 to be sufficient. The minimal clinically important difference for function and strength in patients undergoing reverse shoulder arthroplasty. The final N needed would be 42 patients (21 per group). A randomization of patients will be performed to assign them to one or the other study group, which will be carried out by an independent assistant, who will generate a random sequence that will be unknown to the investigators. Each patient will be given a sealed and numbered envelope to choose from, in which the randomized group in which he/she has been included will be determined. The study will be blinded for the patient and rehabilitator but not for the surgeon.


Recruitment information / eligibility

Status Recruiting
Enrollment 42
Est. completion date December 31, 2025
Est. primary completion date March 1, 2025
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: 1. Male or female patients over 65 years of age with rotator cuff arthropathy refractory to conservative treatment after six months. 2. Ability to understand the information sheet, informed consent and evaluation scales. Exclusion Criteria: Patients with sequelae of fractures, rheumatoid arthritis, avascular necrosis, primary glenohumeral arthrosis, revision surgeries that have required conversion to a ATHI 3. Patients in whom another surgical procedure has been associated with ATHI such as a tendon transfer 4. Glenoid bone defects in the horizontal plane (Type B2 and C of the Walch classification) or in the vertical plane (E3 Sirveaux).

Study Design


Intervention

Procedure:
reverse shoulder arthroplasty
The patient will be admitted to undergo reconstructive surgery of the arthropathy, by means of one of the two mentioned Inverted Arthroplasty implants. The patient will be operated following always the same surgical technique with the same protocol (position, anesthesia, antibiotic prophylaxis...) and by one of the three surgeons of the shoulder unit, being always at least two of them present in each of the interventions. Both the implants used and the complications occurring during surgery or in the immediate postoperative period will be recorded.

Locations

Country Name City State
Spain Hospital Clinico San Carlos de Madrid Madrid

Sponsors (1)

Lead Sponsor Collaborator
Yaiza Lopiz Morales

Country where clinical trial is conducted

Spain, 

References & Publications (5)

Garcia-Fernandez C, Lopiz Y, Rizo B, Serrano-Mateo L, Alcobia-Diaz B, Rodriguez-Gonzalez A, Marco F. Reverse total shoulder arhroplasty for the treatment of failed fixation in proximal humeral fractures. Injury. 2018 Sep;49 Suppl 2:S22-S26. doi: 10.1016/j.injury.2018.06.042. — View Citation

Lopiz Y, Alcobia-Diaz B, Galan-Olleros M, Garcia-Fernandez C, Picado AL, Marco F. Reverse shoulder arthroplasty versus nonoperative treatment for 3- or 4-part proximal humeral fractures in elderly patients: a prospective randomized controlled trial. J Shoulder Elbow Surg. 2019 Dec;28(12):2259-2271. doi: 10.1016/j.jse.2019.06.024. Epub 2019 Sep 6. — View Citation

Lopiz Y, Garcia-Fernandez C, Arriaza A, Rizo B, Marcelo H, Marco F. Midterm outcomes of bone grafting in glenoid defects treated with reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2017 Sep;26(9):1581-1588. doi: 10.1016/j.jse.2017.01.017. Epub 2017 Apr 10. — View Citation

Lopiz Y, Garcia-Fernandez C, Vallejo-Carrasco M, Garriguez-Perez D, Achaerandio L, Tesoro-Gonzalo C, Marco F. Reverse shoulder arthroplasty for proximal humeral fracture in the elderly. Cemented or uncemented stem? Int Orthop. 2022 Mar;46(3):635-644. doi: 10.1007/s00264-021-05284-y. Epub 2022 Jan 16. — View Citation

Lopiz Y, Rodriguez-Gonzalez A, Martin-Albarran S, Marcelo H, Garcia-Fernandez C, Marco F. Injury to the axillary and suprascapular nerves in rotator cuff arthropathy and after reverse shoulder arthroplasty: a prospective electromyographic analysis. J Shoulder Elbow Surg. 2018 Jul;27(7):1275-1282. doi: 10.1016/j.jse.2017.12.030. Epub 2018 Feb 21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary to compare functional outcomes in patients with cuff arthropathies treated with medialized ATHI or lateralized ATHI. To compare functional outcomes (Constant scale score) 24 months after surgery in patients over 65 years of age with cuff arthropathies treated with either of two options: Medialized ATHI or lateralized ATHI. the score ranges from 0-100 points. The higher the score the better the functional result 24 Months
Secondary Comparison of the results of the visual analog pain scale (VAS) Comparison of the results obtained in the other functional assessment scale: the visual analog pain scale (VAS).(0-10). The higher the score, the more painful 24 Months
Secondary Comparison of Joint Range of Motion between the two prosthetic systems under study. Comparison of the joint range of motion (joint balance in degrees in abduction, external and internal rotation, anteversion) between the two prosthetic systems under study. 24 Months
Secondary Analysis and comparison of the Maximum recorded muscle force. Maximum muscle force at any time during a repetition. Indicative of muscle force capacity (N-M, newtons per meter). 24 Months
Secondary Determination and comparison of the prevalence of complications with each of the prosthetic systems. Determination and comparison of the prevalence of complications with each of the prosthetic systems used, including radiographic evaluation. 24 Months
Secondary Comparison of the results of the Quick Disabilities of arm, shoulder and hand (Quick-DASH) score. Comparison of the results obtained in the other functional assessment scale: Quick Disabilities of arm, shoulder and hand (Quick-DASH) score. The score ranges from 0 to 100.
The higher the score, the greater shoulder disability
24 Months
Secondary Comparison of the results of the American Shoulder and Elbow Surgeons score Comparison of the results obtained in the other functional assessment scales: American Shoulder and Elbow Surgeons score. the the score ranges from 0 to 100, where 0 indicates a worse shoulder condition and 100 indicates best shoulder condition, so the greater the score, the lower the level of shoulder disability 24 Months
Secondary Analysis and comparison of the Maximum strength as a function of weight Maximum strength as a function of weight: percentage of muscle strength recorded and normalized by body weight and compared to the set goal ( %). 24 Months
Secondary Analysis and comparison of the Total work per repetition Total work per repetition: total muscle force for the repetition with the greatest amount of work. Work is indicative of the muscle's ability to produce force throughout the range of motion (measured in Joules (J)). 24 Months
Secondary Analysis and comparison of the isokinetic parameter (Coefficient of variation ) Coefficient of variation : Statistical representation of the validity of the test based on the reproducibility of the exercise. Low values show higher reproducibility (%). 24 Months
Secondary Analysis and comparison of the isokinetic parameters (Average power) Average power: total work divided by time. Power represents how fast a muscle can produce force (W, watts). 24 Months
Secondary Analysis and comparison of the Acceleration rate Acceleration rate: total time to reach the Isokinetic speed. Indicative of the neuromuscular capacity to move the limb at the beginning of the Range of Motion (msec. milliseconds). 24 Months
Secondary Analysis and comparison of the Deceleration speed Deceleration speed: total time to go from Isokinetic speed to zero speed. Indicative of the neuromuscular capacity to control the limb eccentrically at the end of the Range of Motion (msec, milliseconds). 24 Months
Secondary Analysis and comparison of the isokinetic parameters (Agonist/antagonist ratio) Agonist/antagonist ratio: The ratio of the reciprocal muscle group. Excessive imbalances may predispose to joint injury.% 24 Months
See also
  Status Clinical Trial Phase
Completed NCT01726972 - A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty
Completed NCT06043544 - Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis: Phase 4
Recruiting NCT04105478 - Comparison of Stemless and Stemmed Shoulder Arthroplasty for Osteoarthritis N/A
Recruiting NCT03866330 - Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis Phase 1/Phase 2
Recruiting NCT04845074 - Prosthesis Versus Active Exercise Program in Patients With Glenohumeral Osteoarthritis N/A
Terminated NCT03586687 - Osteoarthritis Shoulder Injection Study Phase 4
Completed NCT03379545 - 3D MR Versus 3D CT for Glenohumeral Arthritis N/A
Recruiting NCT06269705 - ZILRETTA in Subjects With Glenohumeral Osteoarthritis Phase 3
Active, not recruiting NCT06171542 - Efficacy of a Single Image Guided Injection of CTM for Glenohumeral Arthritis Phase 1
Completed NCT00436969 - ORTHOVISC Shoulder Osteoarthritis Study Phase 3
Recruiting NCT03869229 - Adipose-derived Mesenchymal Stem Cells in Osteoarthritis Phase 1/Phase 2
Completed NCT00500630 - Objective Evaluation of Shoulder Pathology and Surgery N/A